Katrin Pape

1.0k total citations · 1 hit paper
18 papers, 619 citations indexed

About

Katrin Pape is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Katrin Pape has authored 18 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 8 papers in Immunology and 5 papers in Neurology. Recurrent topics in Katrin Pape's work include Multiple Sclerosis Research Studies (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Katrin Pape is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Katrin Pape collaborates with scholars based in Germany, Netherlands and Australia. Katrin Pape's co-authors include Frauke Zipp, Ryad Tamouza, Marion Leboyer, Stefan Bittner, J. Bohner, Andreas Calatzis, M. Spannagl, Tobias Ruck, Sven G. Meuth and Heike Weißer and has published in prestigious journals such as Journal of Clinical Investigation, Brain and Annals of Neurology.

In The Last Decade

Katrin Pape

17 papers receiving 616 citations

Hit Papers

Immunoneuropsychiatry — novel perspectives on brain disor... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunoneuropsychiatry — novel perspectives on brain disorders
    2019 332 citations Katrin Pape, Ryad Tamouza et al. Nature Reviews Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrin Pape Germany 8 169 134 112 112 102 18 619
Amir Ashraf‐Ganjouei Iran 16 42 0.2× 68 0.5× 109 1.0× 76 0.7× 162 1.6× 61 592
Chryssoula Nikolaou Greece 14 172 1.0× 79 0.6× 111 1.0× 105 0.9× 152 1.5× 19 629
Karine Palin France 15 239 1.4× 38 0.3× 129 1.2× 348 3.1× 70 0.7× 20 881
Julie A. Wixey Australia 19 40 0.2× 37 0.3× 158 1.4× 235 2.1× 103 1.0× 44 1.1k
Josiane Lopes Brazil 12 37 0.2× 346 2.6× 104 0.9× 63 0.6× 91 0.9× 35 645
Leman Mutlu United States 8 170 1.0× 80 0.6× 123 1.1× 113 1.0× 192 1.9× 10 568
Harm de Wit Netherlands 14 362 2.1× 21 0.2× 183 1.6× 86 0.8× 43 0.4× 17 867
Zhiqiang Liu China 17 40 0.2× 67 0.5× 128 1.1× 25 0.2× 20 0.2× 48 696
Lorenza Rattazzi United Kingdom 13 75 0.4× 28 0.2× 214 1.9× 82 0.7× 16 0.2× 17 550
Johanna Krüger Finland 12 17 0.1× 213 1.6× 115 1.0× 64 0.6× 190 1.9× 48 664

Countries citing papers authored by Katrin Pape

Since Specialization
Citations

This map shows the geographic impact of Katrin Pape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Pape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Pape more than expected).

Fields of papers citing papers by Katrin Pape

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Pape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Pape. The network helps show where Katrin Pape may publish in the future.

Co-authorship network of co-authors of Katrin Pape

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Pape. A scholar is included among the top collaborators of Katrin Pape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Pape. Katrin Pape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pape, Katrin, Falk Steffen, Sinah Engel, et al.. (2025). Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis. Brain. 149(1). 123–133.
2.
Pape, Katrin, et al.. (2024). Lower leukocytes pretreatment as a possible risk factor for therapy-induced leukopenia in interferon-beta-treated patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 17. 4233567585–4233567585. 1 indexed citations
3.
Pape, Katrin, et al.. (2024). Recurrent late-onset neutropenia following treatment with different B cell-depleting strategies in multiple sclerosis. Med. 6(3). 100529–100529. 2 indexed citations
4.
Steffen, Falk, Tobias Ruck, Katrin Pape, et al.. (2024). Increased Disability Progression in rs10191329AA Carriers with Multiple Sclerosis Is Preceded by Neurofilament Light Chain Elevations. Annals of Neurology. 97(3). 596–605. 4 indexed citations
5.
Bittner, Stefan, Katrin Pape, Luisa Klotz, & Frauke Zipp. (2023). Implications of immunometabolism for smouldering MS pathology and therapy. Nature Reviews Neurology. 19(8). 477–488. 5 indexed citations
6.
Steffen, Falk, et al.. (2023). Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. Med. 4(6). 361–372.e3. 26 indexed citations
7.
Pape, Katrin, et al.. (2023). Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma. Frontiers in Oncology. 13. 1303141–1303141. 2 indexed citations
8.
Pape, Katrin, Leoni Rolfes, Falk Steffen, et al.. (2022). Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study. Therapeutic Advances in Neurological Disorders. 15. 4213424012–4213424012. 4 indexed citations
9.
Eschborn, Melanie, Marc Pawlitzki, Timo Wirth, et al.. (2021). Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 8(6). 37 indexed citations
10.
Loos, Julia A., Steffen Pfeuffer, Katrin Pape, et al.. (2020). MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation. Journal of Neurology. 267(6). 1632–1642. 26 indexed citations
11.
Ellwardt, Erik, Leoni Rolfes, Julia Klein, et al.. (2020). Ocrelizumab initiation in patients with MS. Neurology Neuroimmunology & Neuroinflammation. 7(4). 38 indexed citations
12.
Pape, Katrin, Falk Steffen, Frauke Zipp, & Stefan Bittner. (2020). Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(3). 2455356286–2455356286. 7 indexed citations
13.
Birkner, Katharina, Tobias Ruck, Dirk Luchtman, et al.. (2019). β1-Integrin– and KV1.3 channel–dependent signaling stimulates glutamate release from Th17 cells. Journal of Clinical Investigation. 130(2). 715–732. 37 indexed citations
14.
Pape, Katrin, Ryad Tamouza, Marion Leboyer, & Frauke Zipp. (2019). Immunoneuropsychiatry — novel perspectives on brain disorders. Nature Reviews Neurology. 15(6). 317–328. 332 indexed citations breakdown →
15.
Pape, Katrin, Frauke Zipp, & Stefan Bittner. (2018). Neues aus der Immuntherapie bei Multipler Sklerose. Der Nervenarzt. 89(12). 1365–1370. 1 indexed citations
16.
17.
18.
Bohner, J., et al.. (2007). Vollblutaggregometrie zur Kontrolle der Wirksamkeit von Azetylsalizylsäure bei Patienten mit koronarer Herzkrankheit. Hämostaseologie. 27(3). 155–160. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amir Ashraf‐Ganjouei Breakdown of academic impact, for papers by Chryssoula Nikolaou Breakdown of academic impact, for papers by Karine Palin Breakdown of academic impact, for papers by Julie A. Wixey Breakdown of academic impact, for papers by Josiane Lopes Breakdown of academic impact, for papers by Leman Mutlu Breakdown of academic impact, for papers by Harm de Wit Breakdown of academic impact, for papers by Zhiqiang Liu Breakdown of academic impact, for papers by Lorenza Rattazzi Breakdown of academic impact, for papers by Johanna Krüger
Rankless by CCL
2026